Search
metformin/repaglinide (PrandiMet)
Indication:
- combination therapy for diabetes mellitus type-2
Adverse effects: see metformin, repaglinide
Drug interactions: see metformin, repaglinide
Mechanism of action: see metformin, repaglinide
Interactions
drug interactions
drug adverse effects of hypoglycemic agents
General
hypoglycemic combination
References
- Prescriber's Letter 16(2): 2009
New Drugs Approved by the FDA in 2008
Detail-Document#: 250213
(subscription needed) http://www.prescribersletter.com
Components
metformin (Glucophage)
repaglinide (Prandin)